Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1997 Sep;71(9):6279–6286. doi: 10.1128/jvi.71.9.6279-6286.1997

Transformation and tumorigenic properties of a mutant polyomavirus containing a middle T antigen defective in Shc binding.

X Yi 1, J Peterson 1, R Freund 1
PMCID: PMC191900  PMID: 9261344

Abstract

Polyomavirus middle T antigen is phosphorylated on several tyrosine residues which act as binding sites for cellular proteins, including phosphatidylinositol 3-kinase, Shc, and phospholipase C-gamma. In this report we describe the transforming properties and tumor-inducing ability of a polyomavirus that contains a single-site mutation in middle T antigen which changes a tyrosine residue at amino acid position 250 to serine. This mutation disrupts the association of middle T with the transforming protein Shc. The mutant virus is weakly transforming, inducing foci which are smaller and of different morphology than those of the wild type. Although the virus induced tumors in close to 100% of inoculated mice, the spectrum of tumors and their morphology were altered compared to those of wild-type virus. The mutant virus induced a reduced frequency of kidney and thymic tumors. Both the mammary gland and the thymic tumors that were induced were histologically distinct from those induced by wild-type polyomavirus. These results demonstrate that the signal transduction pathway that is deregulated by the middle T-Shc association is important for full transformation of cells in culture and for tumor induction in some target tissues in the mouse-polyomavirus system.

Full Text

The Full Text of this article is available as a PDF (877.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auger K. R., Carpenter C. L., Shoelson S. E., Piwnica-Worms H., Cantley L. C. Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. J Biol Chem. 1992 Mar 15;267(8):5408–5415. [PubMed] [Google Scholar]
  2. Bauer P. H., Bronson R. T., Fung S. C., Freund R., Stehle T., Harrison S. C., Benjamin T. L. Genetic and structural analysis of a virulence determinant in polyomavirus VP1. J Virol. 1995 Dec;69(12):7925–7931. doi: 10.1128/jvi.69.12.7925-7931.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Benjamin T. L. The hr-t gene of polyoma virus. Biochim Biophys Acta. 1982 Dec 21;695(2):69–95. doi: 10.1016/0304-419x(82)90018-x. [DOI] [PubMed] [Google Scholar]
  4. Blaikie P., Immanuel D., Wu J., Li N., Yajnik V., Margolis B. A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. J Biol Chem. 1994 Dec 23;269(51):32031–32034. [PubMed] [Google Scholar]
  5. Bolen J. B., Thiele C. J., Israel M. A., Yonemoto W., Lipsich L. A., Brugge J. S. Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation. Cell. 1984 Oct;38(3):767–777. doi: 10.1016/0092-8674(84)90272-1. [DOI] [PubMed] [Google Scholar]
  6. Campbell K. S., Ogris E., Burke B., Su W., Auger K. R., Druker B. J., Schaffhausen B. S., Roberts T. M., Pallas D. C. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6344–6348. doi: 10.1073/pnas.91.14.6344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carmichael G. G., Schaffhausen B. S., Dorsky D. I., Oliver D. B., Benjamin T. L. Carboxy terminus of polyoma middle-sized tumor antigen is required for attachment to membranes, associated protein kinase activities, and cell transformation. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3579–3583. doi: 10.1073/pnas.79.11.3579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carmichael G., Schaffhausen B. S., Mandel G., Liang T. J., Benjamin T. L. Transformation by polyoma virus is drastically reduced by substitution of phenylalanine for tyrosine at residue 315 of middle-sized tumor antigen. Proc Natl Acad Sci U S A. 1984 Feb;81(3):679–683. doi: 10.1073/pnas.81.3.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Courtneidge S. A., Smith A. E. Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature. 1983 Jun 2;303(5916):435–439. doi: 10.1038/303435a0. [DOI] [PubMed] [Google Scholar]
  10. DAWE C. J., LAW L. W., DUNN T. B. Studies of parotid-tumor agent in cultures of leukemic tissues of mice. J Natl Cancer Inst. 1959 Oct;23:717–797. [PubMed] [Google Scholar]
  11. Dahl J., Freund R., Blenis J., Benjamin T. L. Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Mol Cell Biol. 1996 Jun;16(6):2728–2735. doi: 10.1128/mcb.16.6.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Dahl J., Thathamangalam U., Freund R., Benjamin T. L. Functional asymmetry of the regions juxtaposed to the membrane-binding sequence of polyomavirus middle T antigen. Mol Cell Biol. 1992 Nov;12(11):5050–5058. doi: 10.1128/mcb.12.11.5050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Damen J. E., Liu L., Rosten P., Humphries R. K., Jefferson A. B., Majerus P. W., Krystal G. The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1689–1693. doi: 10.1073/pnas.93.4.1689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dawe C. J., Freund R., Mandel G., Ballmer-Hofer K., Talmage D. A., Benjamin T. L. Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol. 1987 May;127(2):243–261. [PMC free article] [PubMed] [Google Scholar]
  15. Dilworth S. M., Brewster C. E., Jones M. D., Lanfrancone L., Pelicci G., Pelicci P. G. Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature. 1994 Jan 6;367(6458):87–90. doi: 10.1038/367087a0. [DOI] [PubMed] [Google Scholar]
  16. Druker B. J., Ling L. E., Cohen B., Roberts T. M., Schaffhausen B. S. A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. J Virol. 1990 Sep;64(9):4454–4461. doi: 10.1128/jvi.64.9.4454-4461.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Druker B. J., Sibert L., Roberts T. M. Polyomavirus middle T-antigen NPTY mutants. J Virol. 1992 Oct;66(10):5770–5776. doi: 10.1128/jvi.66.10.5770-5776.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dubensky T. W., Freund R., Dawe C. J., Benjamin T. L. Polyomavirus replication in mice: influences of VP1 type and route of inoculation. J Virol. 1991 Jan;65(1):342–349. doi: 10.1128/jvi.65.1.342-349.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dubensky T. W., Villarreal L. P. The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol. 1984 May;50(2):541–546. doi: 10.1128/jvi.50.2.541-546.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Dyson N., Bernards R., Friend S. H., Gooding L. R., Hassell J. A., Major E. O., Pipas J. M., Vandyke T., Harlow E. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol. 1990 Mar;64(3):1353–1356. doi: 10.1128/jvi.64.3.1353-1356.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Freund R., Bronson R. T., Benjamin T. L. Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene. 1992 Oct;7(10):1979–1987. [PubMed] [Google Scholar]
  22. Freund R., Calderone A., Dawe C. J., Benjamin T. L. Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen. J Virol. 1991 Jan;65(1):335–341. doi: 10.1128/jvi.65.1.335-341.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Freund R., Dawe C. J., Benjamin T. L. Duplication of noncoding sequences in polyomavirus specifically augments the development of thymic tumors in mice. J Virol. 1988 Oct;62(10):3896–3899. doi: 10.1128/jvi.62.10.3896-3899.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Freund R., Dawe C. J., Carroll J. P., Benjamin T. L. Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol. 1992 Dec;141(6):1409–1425. [PMC free article] [PubMed] [Google Scholar]
  25. Freund R., Mandel G., Carmichael G. G., Barncastle J. P., Dawe C. J., Benjamin T. L. Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles. J Virol. 1987 Jul;61(7):2232–2239. doi: 10.1128/jvi.61.7.2232-2239.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Freund R., Sotnikov A., Bronson R. T., Benjamin T. L. Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology. 1992 Dec;191(2):716–723. doi: 10.1016/0042-6822(92)90247-m. [DOI] [PubMed] [Google Scholar]
  27. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  28. Gustafson T. A., He W., Craparo A., Schaub C. D., O'Neill T. J. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol Cell Biol. 1995 May;15(5):2500–2508. doi: 10.1128/mcb.15.5.2500. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Jelinek M. A., Hassell J. A. Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation. Oncogene. 1992 Sep;7(9):1687–1698. [PubMed] [Google Scholar]
  30. Kaplan D. R., Whitman M., Schaffhausen B., Raptis L., Garcea R. L., Pallas D., Roberts T. M., Cantley L. Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc Natl Acad Sci U S A. 1986 Jun;83(11):3624–3628. doi: 10.1073/pnas.83.11.3624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kavanaugh W. M., Williams L. T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 1994 Dec 16;266(5192):1862–1865. doi: 10.1126/science.7527937. [DOI] [PubMed] [Google Scholar]
  32. Kornbluth S., Sudol M., Hanafusa H. Association of the polyomavirus middle-T antigen with c-yes protein. Nature. 1987 Jan 8;325(7000):171–173. doi: 10.1038/325171a0. [DOI] [PubMed] [Google Scholar]
  33. Larose A., Dyson N., Sullivan M., Harlow E., Bastin M. Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization. J Virol. 1991 May;65(5):2308–2313. doi: 10.1128/jvi.65.5.2308-2313.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Li N., Batzer A., Daly R., Yajnik V., Skolnik E., Chardin P., Bar-Sagi D., Margolis B., Schlessinger J. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature. 1993 May 6;363(6424):85–88. doi: 10.1038/363085a0. [DOI] [PubMed] [Google Scholar]
  35. Liang T. J., Carmichael G. G., Benjamin T. L. A polyoma mutant that encodes small T antigen but not middle T antigen demonstrates uncoupling of cell surface and cytoskeletal changes associated with cell transformation. Mol Cell Biol. 1984 Dec;4(12):2774–2783. doi: 10.1128/mcb.4.12.2774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Markland W., Oostra B. A., Harvey R., Markham A. F., Colledge W. H., Smith A. E. Site-directed mutagenesis of polyomavirus middle-T antigen sequences encoding tyrosine 315 and tyrosine 250. J Virol. 1986 Aug;59(2):384–391. doi: 10.1128/jvi.59.2.384-391.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Markland W., Smith A. E. Mutants of polyomavirus middle-T antigen. Biochim Biophys Acta. 1987 Nov 25;907(3):299–321. doi: 10.1016/0304-419x(87)90011-4. [DOI] [PubMed] [Google Scholar]
  38. Pallas D. C., Schley C., Mahoney M., Harlow E., Schaffhausen B. S., Roberts T. M. Polyomavirus small t antigen: overproduction in bacteria, purification, and utilization for monoclonal and polyclonal antibody production. J Virol. 1986 Dec;60(3):1075–1084. doi: 10.1128/jvi.60.3.1075-1084.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., Pelicci P. G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 1992 Jul 10;70(1):93–104. doi: 10.1016/0092-8674(92)90536-l. [DOI] [PubMed] [Google Scholar]
  40. ROWE W. P., HARTLEY J. W., ESTES J. D., HUEBNER R. J. Studies of mouse polyoma virus infection. 1. Procedures for quantitation and detection of virus. J Exp Med. 1959 Apr 1;109(4):379–391. doi: 10.1084/jem.109.4.379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Raptis L., Lamfrom H., Benjamin T. L. Regulation of cellular phenotype and expression of polyomavirus middle T antigen in rat fibroblasts. Mol Cell Biol. 1985 Sep;5(9):2476–2486. doi: 10.1128/mcb.5.9.2476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Raptis L., Marcellus R., Corbley M. J., Krook A., Whitfield J., Anderson S. K., Haliotis T. Cellular ras gene activity is required for full neoplastic transformation by polyomavirus. J Virol. 1991 Oct;65(10):5203–5210. doi: 10.1128/jvi.65.10.5203-5210.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Rodriguez-Viciana P., Warne P. H., Dhand R., Vanhaesebroeck B., Gout I., Fry M. J., Waterfield M. D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 1994 Aug 18;370(6490):527–532. doi: 10.1038/370527a0. [DOI] [PubMed] [Google Scholar]
  44. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thomas S., Brugge J., Pelicci P. G. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 1992 Dec 17;360(6405):689–692. doi: 10.1038/360689a0. [DOI] [PubMed] [Google Scholar]
  45. Schaffhausen B. S., Benjamin T. L. Phosphorylation of polyoma T antigens. Cell. 1979 Dec;18(4):935–946. doi: 10.1016/0092-8674(79)90206-x. [DOI] [PubMed] [Google Scholar]
  46. Southern P. J., Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet. 1982;1(4):327–341. [PubMed] [Google Scholar]
  47. Su W., Liu W., Schaffhausen B. S., Roberts T. M. Association of Polyomavirus middle tumor antigen with phospholipase C-gamma 1. J Biol Chem. 1995 May 26;270(21):12331–12334. doi: 10.1074/jbc.270.21.12331. [DOI] [PubMed] [Google Scholar]
  48. Talmage D. A., Freund R., Young A. T., Dahl J., Dawe C. J., Benjamin T. L. Phosphorylation of middle T by pp60c-src: a switch for binding of phosphatidylinositol 3-kinase and optimal tumorigenesis. Cell. 1989 Oct 6;59(1):55–65. doi: 10.1016/0092-8674(89)90869-6. [DOI] [PubMed] [Google Scholar]
  49. Treisman R., Novak U., Favaloro J., Kamen R. Transformation of rat cells by an altered polyoma virus genome expressing only the middle-T protein. Nature. 1981 Aug 13;292(5824):595–600. doi: 10.1038/292595a0. [DOI] [PubMed] [Google Scholar]
  50. Urich M., el Shemerly M. Y., Besser D., Nagamine Y., Ballmer-Hofer K. Activation and nuclear translocation of mitogen-activated protein kinases by polyomavirus middle-T or serum depend on phosphatidylinositol 3-kinase. J Biol Chem. 1995 Dec 8;270(49):29286–29292. doi: 10.1074/jbc.270.49.29286. [DOI] [PubMed] [Google Scholar]
  51. WINOCOUR E. Purification of polyoma virus. Virology. 1963 Feb;19:158–168. doi: 10.1016/0042-6822(63)90005-9. [DOI] [PubMed] [Google Scholar]
  52. Whitman M., Kaplan D. R., Schaffhausen B., Cantley L., Roberts T. M. Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature. 1985 May 16;315(6016):239–242. doi: 10.1038/315239a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES